A PHP Error was encountered

Severity: Warning

Message: file_get_contents(https://...@gmail.com&api_key=61f08fa0b96a73de8c900d749fcb997acc09): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests

Filename: helpers/my_audit_helper.php

Line Number: 143

Backtrace:

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 143
Function: file_get_contents

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 209
Function: simplexml_load_file_from_url

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3098
Function: getPubMedXML

File: /var/www/html/application/controllers/Detail.php
Line: 574
Function: pubMedSearch_Global

File: /var/www/html/application/controllers/Detail.php
Line: 488
Function: pubMedGetRelatedKeyword

File: /var/www/html/index.php
Line: 316
Function: require_once

A PHP Error was encountered

Severity: Warning

Message: Attempt to read property "Count" on bool

Filename: helpers/my_audit_helper.php

Line Number: 3100

Backtrace:

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3100
Function: _error_handler

File: /var/www/html/application/controllers/Detail.php
Line: 574
Function: pubMedSearch_Global

File: /var/www/html/application/controllers/Detail.php
Line: 488
Function: pubMedGetRelatedKeyword

File: /var/www/html/index.php
Line: 316
Function: require_once

Neoadjuvant chemotherapy with different dose regimens of docetaxel, cisplatin and fluorouracil (TPF) for locoregionally advanced nasopharyngeal carcinoma: a retrospective study. | LitMetric

AI Article Synopsis

  • The study aimed to compare the effectiveness and side effects of high-dose TPF (H-TPF) and low-dose TPF (L-TPF) neoadjuvant chemotherapy in Chinese patients with advanced nasopharyngeal carcinoma (NPC).
  • A total of 210 patients were analyzed, with higher treatment delays and more severe side effects (anemia, thrombocytopenia, neutropenia) seen in the H-TPF group compared to the L-TPF group.
  • Despite these differences in tolerance, the overall effectiveness in terms of progression-free survival and overall survival rates was similar between H-TPF and L-TPF, suggesting L-TPF is a more

Article Abstract

Objective: Compare high- vs. low-dose TPF neoadjuvant chemotherapy with chemoradiotherapy in Chinese patients with locoregionally advanced nasopharyngeal carcinoma (NPC).

Materials And Methods: Retrospective analysis of 210 stage III/IV NPC patients treated between April 1, 2012 and April 1, 2014; 138 received three cycles of high-dose TPF (H-TPF) every 3 weeks at Zhejiang Cancer Hospital and 72, three cycles of low-dose TPF (L-TPF) every 3 weeks at Sun Yat-Sen University Cancer Center. H-TPF was docetaxel (75 mg/m; 1 h infusion), cisplatin (75 mg/m; 0.5-3 h), then 5-fluorouracil (600 mg/m2/day; 4 days). L-TPF was docetaxel (60 mg/m), cisplatin (65 mg/m), then 5-fluorouracil (550 mg/m/day; 5 days). All patients received chemoradiotherapy.

Results: During neoadjuvant chemotherapy, treatment delays were more frequent for H-TPF than L-TPF (33.3% vs. 19.4%; = 0.034). During chemoradiotherapy, grade III-IV anemia, thrombocytopenia and neutropenia were more common for H-TPF than L-TPF ( < 0.001, < 0.001, = 0.048). Fewer patients in the H-TPF group finished two cycles of concurrent chemotherapy (81.2% vs. 100%, < 0.001). Three-year PFS (84.5% vs. 80.6%, = 0.484) and OS (91.1% vs. 93.5%, = 0.542) were not significantly different between H-TPF and L-TPF.

Conclusions: L-TPF neoadjuvant chemotherapy has substantially better tolerance and compliance rates and similar treatment efficacy to H-TPF neoadjuvant chemotherapy in locoregionally-advanced NPC.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725062PMC
http://dx.doi.org/10.18632/oncotarget.21992DOI Listing

Publication Analysis

Top Keywords

neoadjuvant chemotherapy
20
locoregionally advanced
8
advanced nasopharyngeal
8
nasopharyngeal carcinoma
8
low-dose tpf
8
three cycles
8
docetaxel mg/m
8
cisplatin mg/m
8
h-tpf l-tpf
8
h-tpf
7

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!